Diagnosticos da America (BSP:DASA3) 5-Year EBITDA Growth Rate : 9.10% (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Diagnosticos da America 5-Year EBITDA Growth Rate?

Diagnosticos da America's EBITDA per Share for the three months ended in Mar. 2024 was R$0.80.

During the past 12 months, Diagnosticos da America's average EBITDA Per Share Growth Rate was -31.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 15.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 9.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Diagnosticos da America was 26.10% per year. The lowest was -16.00% per year. And the median was 5.80% per year.

Competitive Comparison of Diagnosticos da America's 5-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Diagnosticos da America's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diagnosticos da America's 5-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diagnosticos da America's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Diagnosticos da America's 5-Year EBITDA Growth Rate falls into.

Diagnosticos da America 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Diagnosticos da America (BSP:DASA3) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Diagnosticos da America 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Diagnosticos da America's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnosticos da America (BSP:DASA3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diagnosticos da America SA (BSP:DASA3) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010

Website

https://www.dasa3.com.br

Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).

Diagnosticos da America (BSP:DASA3) Headlines

No Headlines